1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Josef Stehlik: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and Inflammation Vericiguat, Placebo - Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF) | Phase 4 | Completed | Josef Stehlik | 26 | 2023-05-01 | 2025-10-08 |
Heart Failure (1)
Control Groups (1) · vericiguat (1)
United States (1)